CLINICAL_TRIALS
research
· 2025-09-29
Clinical Trial Update: CYFIP1 and PKM2 Synergistically Regulate ROS and Glycolysis in Colorectal Cancer Through the AKT/mTOR/HIF-1α Cascad
Summary
A completed mechanistic study in colorectal cancer examining how CYFIP1 and PKM2 jointly regulate reactive oxygen species and glycolysis through the AKT/mTOR/HI…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: hui hou | Conditions: Colorectal Cancer (CRC), Specimens Are to be Collected From Subjects Who Are Having or Have Had a Fluid or Tissue Removed, a Biopsy or a Blood or Bone Marrow Draw | Status: COMPLETED